Cresco Labs (OTCMKTS:CRLBF) Shares Down 0.6% – Should You Sell?

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF) traded down 0.6% during trading on Monday . The stock traded as low as $0.86 and last traded at $0.89. 313,011 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 539,036 shares. The stock had previously closed at $0.89.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Roth Capital upgraded shares of Cresco Labs to a “strong-buy” rating in a report on Sunday, November 10th. Cormark lowered shares of Cresco Labs from a “moderate buy” rating to a “hold” rating in a research report on Monday, November 11th. Finally, Atb Cap Markets lowered shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 9th. Four analysts have rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $2.50.

Cresco Labs Price Performance

The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The stock has a market cap of $432.00 million, a P/E ratio of -4.43 and a beta of 1.79. The business’s 50-day simple moving average is $0.92 and its two-hundred day simple moving average is $1.29.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.